MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neurophysiological Assessment of Juvenile Parkinsonism due to Primary Monoamine Neurotransmitters Disorders

M. Passaretti, L. Pollini, G. Paparella, A. de Biase, D. Colella, S. Galosi, F. Manti, A. Guerra, V. Leuzzi, A. Berardelli, M. Bologna (Rome, Italy)

Meeting: 2022 International Congress

Abstract Number: 680

Keywords: Bradykinesia, Pediatric neurotransmitter diseases, Transcranial magnetic stimulation(TMS)

Category: Neurophysiology (Non-PD)

Objective: No previous studies investigated voluntary movements abnormalities and their neurophysiological correlates in primary monoamine neurotransmitters (NT) disorders.

Background: Juvenile parkinsonism is a rare condition due to various causes, including inherited primary NT disorders, a group of potentially treatable inborn errors of metabolism.

Method: Nine monoamine NT disorders patients and 16 age-matched healthy controls (HCs) were enrolled. Objective measurements of repetitive finger tapping were obtained using a motion analysis system. The excitability of the primary motor cortex (M1) was assessed by recording the input/output (I/O) curve of the motor-evoked potentials (MEP) and using a conditioning-test paradigm for the assessment of short-interval intracortical inhibition (SICI). Plasticity-like mechanisms of M1 were indexed according to the amplitude changes in MEP after the paired associative stimulation (PAS) protocol. Patients’ values 2 standard deviation (SD) aside from the average of the HCs values were considered abnormal.

Results: Patients with aromatic aminoacid decarboxylase, tyrosine hydroxylase and 6-pyruvoyl-tetrahydropterin synthase defects showed markedly reduced velocity (5 out of 5 patients, 100%), reduced movement amplitude and an irregular movement rhythm (4/5 patients, 80%). Conversely, most of the patients with GTP cyclohydrolase I deficiency showed parameters within the normal range (2/3, 66.6%). Interestingly, no patient had a progressive reduction of movement amplitude and velocity during the tapping sequence, i.e., no sequence effect (0%, 0/9) [table 1]. The prominent TMS abnormality in patients was the reduction of SICI (55.5%, 5/9). Also, GTP cyclohydrolase I deficiency patients had a reduction of corticospinal excitability, as shown by a flatter I/O curve (3/3, 100%) and a reduced response to PAS (2/3, 66.6%) [table 2]. Finally, movement velocity inversely correlated with the I/O curve slope in patients (R=-0.78, p=0.036).

Conclusion: We provided an objective assessment of finger tapping abnormalities in monoamine NT disorder. We demonstrated a relation between movement slowness and excitability changes of M1. Our results may be interpreted for a better understanding of the pathophysiology of juvenile parkinsonism due to dopamine deficiency.

Table 1

Table 2

Table 3

To cite this abstract in AMA style:

M. Passaretti, L. Pollini, G. Paparella, A. de Biase, D. Colella, S. Galosi, F. Manti, A. Guerra, V. Leuzzi, A. Berardelli, M. Bologna. Neurophysiological Assessment of Juvenile Parkinsonism due to Primary Monoamine Neurotransmitters Disorders [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/neurophysiological-assessment-of-juvenile-parkinsonism-due-to-primary-monoamine-neurotransmitters-disorders/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neurophysiological-assessment-of-juvenile-parkinsonism-due-to-primary-monoamine-neurotransmitters-disorders/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley